20/20 Biolabs, Inc. (AIDX)
NASDAQ · Healthcare
20/20 Biolabs, Inc. Income Statement 2024–2025
| Dec 2025 | Dec 2024 | |
|---|---|---|
| Revenues | ||
| Revenue | 2.0M | 1.8M |
| Gross Profit | 604,541 | 360,311 |
| Profitability | ||
| Operating Income | -3.3M | -5.7M |
| EBITDA | -3.3M | -5.6M |
| Net Income | -3.7M | -5.6M |
| Per Share Data | ||
| EPS (diluted) | — | — |
| Shares Outstanding (dil.) | 5M | 5M |
20/20 Biolabs, Inc. Income Statement — FAQ
20/20 Biolabs, Inc. (AIDX) income statement over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AIDX's income statement history?
The chart and table above show 20/20 Biolabs, Inc.'s income statement by year and by quarter, including the growth rate.